These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17013446)

  • 41. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
    Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small intestine bacterial overgrowth in patients with irritable bowel syndrome.
    Carrara M; Desideri S; Azzurro M; Bulighin GM; Di Piramo D; Lomonaco L; Adamo S
    Eur Rev Med Pharmacol Sci; 2008; 12(3):197-202. PubMed ID: 18700692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
    Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
    Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.
    Ringel Y; Williams RE; Kalilani L; Cook SF
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of irritable bowel-type symptoms and healthcare-seeking behavior among adults with celiac disease.
    Häuser W; Musial F; Caspary WF; Stein J; Stallmach A
    Psychosom Med; 2007 May; 69(4):370-6. PubMed ID: 17470666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
    Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
    J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bowel symptoms in nonerosive gastroesophageal reflux disease: nature, prevalence, and relation to acid reflux.
    Zimmerman J; Hershcovici T
    J Clin Gastroenterol; 2008 Mar; 42(3):261-5. PubMed ID: 18223499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional chest pain: esophageal or overlapping functional disorder.
    Mudipalli RS; Remes-Troche JM; Andersen L; Rao SS
    J Clin Gastroenterol; 2007 Mar; 41(3):264-9. PubMed ID: 17426464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidimensionality of symptom complexes in irritable bowel syndrome and other functional gastrointestinal disorders.
    Alpers DH
    J Psychosom Res; 2008 Jun; 64(6):567-72. PubMed ID: 18501256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life.
    Frankhuisen R; Van Herwaarden MA; Heijkoop R; Baron A; Vermeijden R; Smout AJ; Gooszen HG; Samsom M
    Scand J Gastroenterol; 2009; 44(6):687-91. PubMed ID: 19263270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
    Lee SY; Lee KJ; Kim SJ; Cho SW
    Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What do patients with irritable bowel syndrome know about their disorder and how do they use their knowledge?
    Ringström G; Agerforz P; Lindh A; Jerlstad P; Wallin J; Simrén M
    Gastroenterol Nurs; 2009; 32(4):284-92. PubMed ID: 19696605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of Rome III criteria for diagnosing irritable bowel syndrome].
    Hattori T; Fukudo S
    Nihon Rinsho; 2006 Aug; 64(8):1425-8. PubMed ID: 16898606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Irritable bowel syndrome: a co-twin control analysis.
    Wojczynski MK; North KE; Pedersen NL; Sullivan PF
    Am J Gastroenterol; 2007 Oct; 102(10):2220-9. PubMed ID: 17897337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparative analysis of efficiency of the estimation of quality of life in patients with irritable bowel syndrome using questionnaires IBS-QOL and index BEST].
    Pilipenko VI; Isakov VA
    Eksp Klin Gastroenterol; 2008; (6):4-8. PubMed ID: 19334419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of culture on symptom reporting: Hispanics and irritable bowel syndrome.
    Barakzai MD; Gregory J; Fraser D
    J Am Acad Nurse Pract; 2007 May; 19(5):261-7. PubMed ID: 17489959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.
    Ruigómez A; García Rodríguez LA; Panés J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):465-9. PubMed ID: 17445753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population.
    Cheung TK; Lam KF; Hu WH; Lam CL; Wong WM; Hui WM; Lai KC; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2007 May; 25(9):1099-104. PubMed ID: 17439511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.